ES|EN
Skip to content
se habla de ...

Ultrasound screening: a two-year interval balances detection and recall burden

Molecular profiling of brain metastases changes systemic treatment

19 October, World Breast Cancer Day: what the evidence says about early detection

San Antonio hosts the world’s largest breast cancer research meeting in December

An analysis questions the risk-based screening endorsed by the WISDOM trial

Fragmented care marks the journey of women living with and beyond breast cancer

ESMO 2026 brings the global oncology community to Madrid on 23-27 October

Education and exercise help sustain breast cancer-specific quality of life in survivors

Immune and proliferation signatures point in opposite directions in stage I TNBC

Wider access to T-DM1 and pertuzumab could avert deaths from HER2+ cancer in Brazil

Supine MRI may reduce positive margins in breast-conserving surgery

Five-fraction breast radiotherapy: good tolerability and early tumour control

Neutrophil-to-lymphocyte ratio may predict pembrolizumab response in TNBC

A 50% oestrogen-receptor cutoff defines a poorly responding HER2+ subgroup

The gut microbiota-obesity axis in breast cancer: mechanisms and opportunities

De-escalating neoadjuvant therapy in HER2-positive breast cancer: who and how?

AI combines MRI radiomics and perfusion to predict response to neoadjuvant chemotherapy

Food insecurity linked to worse survival in locally advanced breast cancer

Meridian sinew tuina reduces upper limb swelling in post-surgical lymphedema

A breast tissue-specific epigenetic clock improves age estimates in breast tissue

Oncomama
Oncomama

Papers de oncología de mama y avances de las unidades de mama en España

  • Diagnosis
    • Prevention & Screening
    • Breast Units
  • Treatment
    • Surgery & Reconstruction
  • Research
    • Meetings
    • Bibliomama Library
opciones
  • Diagnosis
    • Prevention & Screening
    • Breast Units
  • Treatment
    • Surgery & Reconstruction
  • Research
    • Meetings
    • Bibliomama Library
  • Breast Units
  • Prevention & Screening

Ultrasound screening: a two-year interval balances detection and recall burden

An analysis of 1.69 million ultrasound screening examinations in Shenzhen proposes a two-year interval for women aged 40 to 64, with different BI-RADS management pathways and prompt biopsy for categories 4B, 4C and 5....

oncomama
Breast Cancer ResOctober 14, 2026
  • Research
  • Treatment

Molecular profiling of brain metastases changes systemic treatment

oncomama
Int J CancerOctober 14, 2026
  • Prevention & Screening

19 October, World Breast Cancer Day: what the evidence says about early detection

oncomama
OMS / IARC / SEOMOctober 13, 2026
  • Meetings
  • Research

San Antonio hosts the world’s largest breast cancer research meeting in December

oncomama
SABCS 2026October 13, 2026
  • Breast Units
  • Prevention & Screening

An analysis questions the risk-based screening endorsed by the WISDOM trial

oncomama
J Breast ImagingOctober 13, 2026
Fragmented care marks the journey of women living with and beyond breast cancer
Breast Cancer ResOctober 12, 2026
ESMO 2026 brings the global oncology community to Madrid on 23-27 October
ESMO 2026October 12, 2026
Education and exercise help sustain breast cancer-specific quality of life in survivors
Breast CancerOctober 12, 2026
Wider access to T-DM1 and pertuzumab could avert deaths from HER2+ cancer in Brazil
BreastOctober 11, 2026
Immune and proliferation signatures point in opposite directions in stage I TNBC
Eur J CancerOctober 11, 2026
Supine MRI may reduce positive margins in breast-conserving surgery
Clin Breast CancerOctober 10, 2026
Copyright © 2026 | Powered by News Magazine X
oncomama  ·  oncohub  ·  disforia
Desarrollado por dosier.es y diseñado por marta ai